-
Late India charge seals thrilling second T20 win over New Zealand
-
Police fire tear gas as new French demonstrations kick off
-
Seen and heard at France protests
-
Tropical Storm Champi nears China after battering Taiwan, Japan
-
White says Fiji can have 'massive' World Cup after beating Japan
-
'Weeks, not days' in Kompany recovery, say Bayern
-
England thrash France 82-0 to keep Rugby League World Cup hopes alive
-
Unfair to compare us to Barca: Real Madrid's Mourinho
-
Security high as France braces for new protests
-
North Korea's Kim makes unannounced visit to Chinese border city
-
White makes winning start as Fiji edge Eddie Jones's Japan
-
Fire breaks out at Hitler's mountain retreat, suspect arrested
-
Lula, Bolsonaro strike calmer tone in final Brazil election debate
-
Marc Marquez wins Australian sprint as Martin crashes out
-
'How is it possible?': Students protest Indonesian haze
-
North Korea's Kim calls for training world's 'strongest' military
-
Israel launches major West Bank operation after soldiers killed
-
Brewers edge Rays to capture World Series opener
-
Typhoon Champi knocks out power to thousands in Taiwan
-
France to deploy 70,000 police for fresh weekend protests
-
As Israeli election nears, campaign turns ugly
-
Tatum delivers as Celtics down winless Knicks
-
Oscar hopeful 'La Bola Negra' offers lessons about communicating, directors say
-
Romantasy fans ready for sleepless night as 'Court of Thorns and Roses' returns
-
Trapped: Soaring fuel costs hurt Maine lobster industry before midterms
-
De Goede hat-trick as Canada defeat England again
-
Marc Marquez beats brother Alex to Australian MotoGP pole
-
How to Build an Emergency Fund for Your Furry Best Friend
-
5 Ways to Prepare Financially for Parenthood
-
Robot Consulting Announces Receipt of Nasdaq Delisting Determination and Request to Appeal such Determination Before a Hearings Panel
-
Rubio urges Cubans to work with CIA, but warns: be discreet
-
Ebola vaccine trial begins in DR Congo
-
Leclerc tops times for Ferrari in practice for US Grand Prix
-
Travelling man Wade equals Prem try record
-
Lula, Bolsonaro lock horns in final debate before Brazil vote
-
Rescuers search for seven people in Nairobi building collapse
-
Poulter and Hatton leave LIV Golf
-
Sacha Baron Cohen revives the 'problematic dinosaur' Ali G in new film
-
Blakely vaults out of the shadow of Biles for all-around world title
-
New race in Barcelona tops 17-event '27 IndyCar season
-
Oil tops $116 with stocks mixed on earnings, AI
-
Neymar backs Flavio Bolsonaro in Brazil election
-
Trump orders lawsuit to block Alaska Senate result if Republicans lose
-
Melania Trump says she brokered truce in war-torn Ukrainian city
-
Ebola patient in Nigeria is Swiss, had not visited DR Congo: Bern
-
Leclerc tops times for Ferrari in opening practice for US Grand Prix
-
Messi receives top Spanish award from heir to throne
-
Bayern Munich coach Kompany in hospital after collapsing
-
Macron condemns 'racist terrorist attack' after deadly shooting near Paris
-
Signs point to renewed major US military ops against Iran
Yunu Launches De-ID & Export to Simplify Site-to-Sponsor Trial Data Sharing
New Capabilities Help Sites Anonymize and Export Trial Images and Results With Greater Control, Stronger Traceability, and Less Manual Effort
CARY, NC / ACCESS Newswire / May 26, 2026 / Yunu today announced De-ID & Export, a new add-on capability designed to give sites a streamlined way to anonymize and export trial images and results directly from their existing workflow.
For many research teams, retrieving and sharing trial data still depends on inefficient PACS retrieval workflows, disconnected downloads, separate anonymization steps, and repeated handoffs between sites and sponsors. The result is burdensome, manual work with weak traceability that slows trial execution when teams are forced to sift through images and prepare data by hand.
Yunu's De-ID & Export capability organizes the workflow, making the process easier.
Built within the Yunu platform, De-ID & Export gives sites a more controlled, technology-forward way to export trial images and results, apply optional trial-specific de-identification, and manage data access through role-based permissions. De-ID & Export supports trial, patient, and timepoint-level workflows. It includes trial images, results, and attachments, while Subject ID mapping helps support privacy and traceability across site-to-sponsor data handoff.
"Sites have shared that anonymizing and exporting trial imaging are some of the hardest and most frustrating parts of delivering data to sponsors," said Gordon Harris, Co-founder & Chief Science Officer of Yunu. "Our team is made up of trial veterans who understand these problems firsthand. Yunu is designed to simplify these types of complex challenges that have been the bane of trial programs for years. What once took weeks can now be done in minutes, with stronger control and less operational friction."
Ahead of its official release, Yunu's De-ID & Export has already been exceptionally well received and actively adopted by leading cancer centers. While designed to help teams reduce repetitive work and improve data delivery, the new capability more broadly reflects Yunu's view that source data from clinical trial imaging is central to many trial decisions and should be shared through collaborative real-time workflows that make data more accessible and actionable for the teams who depend on it.
Organizations interested in learning more about De-ID & Export can contact Yunu directly.
Yunu will be exhibiting at the American Society of Clinical Oncology's (ASCO) Annual Meeting this weekend, from Saturday, May 30th, to Monday, June 1st, at Booth #37115. Visit Yunu at ASCO or connect with the team by visiting yunu.io/contact-us.
About Yunu
Yunu is a clinical trial imaging platform that helps connect imaging workflows, data quality, and trial oversight across research sites and sponsors. By streamlining imaging operations and improving access to trial data, Yunu supports more efficient and compliant clinical trial execution.
Contact:
Lindsay Fleming
Chief Marketing Officer
[email protected]
SOURCE: Yunu
View the original press release on ACCESS Newswire
B.Finley--AMWN